(Q59566205)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

L M Krug

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

V A Miller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G P Kalemkerian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M J Kraut

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K K Ng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R T Heelan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B A Pizzo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W Perez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

N McClean

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

227-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349209956

7 January 2021

Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349209956

7 January 2021

Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349209956

7 January 2021

Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349209956

7 January 2021

Identifiers

DOI

10.1023/A:1008349209956

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761761%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference